In this study we examine the association between the CYP17 promoter T→C and CYP19 TTTA repeat polymorphisms and female breast cancer by using a family-based design among nuclear families participating in the Metropolitan New York Registry (MNYR), one of the six international centers of the National Cancer Institute's Breast Cancer Family Registry project. The gene discussed is CYP17A1; the disease is breast cancer.